Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp RVXCF


Primary Symbol: T.RVX

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > no resistance, wheeeeee
View:
Post by general360 on Jun 01, 2022 5:37pm

no resistance, wheeeeee

all the way down thru the 20's.... no resitance. like a knife thru warm butta...

thanks DM and the useless twits on the board....

speaking of, i just withheld my votes for ALL OF THEM.  they're about as useful as t*ts on a bull.  thats what i think of the lot of them.

a big ole FU and a job well done to them all.
i was thinking w/ the "resignation" of good ole norma, mabye we'd get a slot to fill on the board w/ someone of value. guess not if we're whittling the number of useless fools to 5 from 6.

carry on management, carry on...
Be the first to comment on this post